Covid-19 Infection among Pregnant Women: An Overview of Diagnosis, Treatment and Clinical Management

Abstract

Coronavirus disease or more popularly called COVID-19 is known to be caused by a novel coronavirus 2. COVID-19 has been identified to be originated in Wuhan, Hubei, China. This pandemic started in December 2019, and since then it has spread across the world within a short period. In the current scenario, no specific anti-viral drug is recommended for COVID-19 management. Vulnerable populations, such as pregnant women infected with COVID-19, must be identified and followed up on in order to effectively manage morbidity and mortality. In India, very few case reports on COVID-19-infected pregnant women have been published, and no proven exclusive treatment protocol exists. This article summarizes a review of COVID-19 infection in pregnant women, including signs and symptoms, etiopathogenesis, risk factors, diagnosis, and possible management. This overview may be helpful for medical professionals in terms of the practical approach and limitations of the drugs used in the current management, and it takes into account the selection of drugs with special attention paid to side effects in order to improve maternal health, pregnancy, and birth outcomes.